ANGPTL4 plays a tumor suppressive role in HCC, whereas in PDAC and breast cancer it promotes aggressiveness thanks to its effects on endothelial integrity and cellular migration. This evidence concerns the gene ANGPTL4 and hepatocellular carcinoma.